Peptide T is an octapeptide from the V2 region of HIV-1 gp120. This synthetic octapeptide potentially functions through competitive inhibition of gp120 binding to the CD4 receptor, as well as interaction with vasointestinal peptide (VIP) receptors.
Peptide T (TFA) is an octapeptide derived from the V2 region of HIV-1 gp120. It serves as a ligand for the CD4 receptor, effectively inhibiting the binding of HIV to the CD4 receptor.
ATWLPPR Peptide TFA is a selective neuropilin-1 inhibitor and inhibits VEGF165 binding to NRP-1. It has the potential in reducing the early retinal damage caused by diabetes.